Amy Moore

Amy Moore

Auto-generated profile, based on publicly available information

Amy Moore

RTI International, Waltham, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2024 in Blood
Verified
Journal Article
Closed access
PDF file
TNTravis Nemkov
Travis Nemkov
DSDaniel Stephenson
Daniel Stephenson
CEChristopher Erickson
Christopher Erickson
MDMonika Dzieciatkowska
Monika Dzieciatkowska
AKAlicia Key
Alicia Key
Angelo D'AlessandroAngelo D'Alessandro
Angelo D'Alessandro
In the field of transfusion medicine, the clinical relevance of the metabolic markers of the red blood cell (RBC) storage lesion is incompletely understood. Here, we performed metabolomics of RBC units from 643 donors enrolled in the Recipient Epidemiology and Donor Evaluation Study, REDS RBC Omics. These units were tested on storage days 10, 23, and 42 for a total of 1929 samples and also characterized for end-of-storage hemolytic propensity after oxidative and osmotic insults. Our results indicate that the metabolic markers of the storage lesion poorly correlated with hemolytic propensity. In contrast, kynurenine was not affected by storage duration and was identified as the top predictor of osmotic fragility. RBC kynurenine levels were affected by donor age and body mass index and were reproducible within the same donor across multiple donations from 2 to 12 months apart. To delve into the genetic underpinnings of kynurenine levels in stored RBCs, we thus tested kynurenine levels in stored RBCs on day 42 from 13 091 donors from the REDS RBC Omics study, a population that was also genotyped for 879 000 single nucleotide polymorphisms. Through a metabolite quantitative trait loci analysis, we identified polymorphisms in SLC7A5, ATXN2, and a series of rate-limiting enzymes (eg, kynurenine monooxygenase, indoleamine 2,3-dioxygenase, and tryptophan dioxygenase) in the kynurenine pathway as critical factors affecting RBC kynurenine levels. By interrogating a donor-recipient linkage vein-to-vein database, we then report that SLC7A5 polymorphisms are also associated with changes in hemoglobin and bilirubin levels, suggestive of in vivo hemolysis in 4470 individuals who were critically ill and receiving single-unit transfusions.

11 August 2025 in Blood Red Cells & Iron
Verified
Journal Article
Open access
DSDaniel Stephenson
Daniel Stephenson
GKGregory Keele
Gregory Keele
AHAriel Hay
Ariel Hay
MDMonika Dzieciatkowska
Monika Dzieciatkowska
JRJulie A. Reisz
Julie A. Reisz
Angelo D'AlessandroAngelo D'Alessandro
Angelo D'Alessandro
Red blood cell (RBC) membrane lipid peroxidation during blood bank storage profoundly impacts transfusion efficacy; however, the genetic determinants underlying RBC resilience remain incompletely defined. Here, we identify a critical role for glutathione peroxidase 4 (GPX4) - a pivotal enzyme protecting against iron-dependent lipid peroxidation (ferroptosis) - in regulating RBC storage quality and post-transfusion survival. Conditional erythroid-specific deletion of Gpx4 in mice exacerbated lipid hydroperoxide accumulation, oxidation and ubiquitination of membrane proteins, and reduced RBC recovery after transfusion. Multi-omics analyses in 13,091 human blood donors from the REDS RBC Omics cohort identified regulatory intergenic (rs8178962), intronic and missense genetic variants in GPX4 (rs73507255, rs8178967), particularly prevalent among donors of African descent, that were linked to increased lipid peroxidation and compromised post-transfusion hemoglobin increments. Single protein- and metabolome-wide association studies (pQTL/mQTL) highlighted genetic variants associated with enhanced (rs8178962) or impaired GPX4 expression, disrupted glutathione homeostasis, lipid hydroperoxide accumulation, accelerated membrane damage, and activation of ferroptotic signatures during RBC storage. These effects were exacerbated by genetic traits impairing redox homeostasis, including glucose 6-phosphate dehydrogenase (G6PD) deficiency (African variant rs1050828 V68M/N126D). Storage of murine RBCs in presence of the ferroptosis inhibitor ferrostatin-1 prevented storage-induced lipid peroxidation and boosted post-transfusion recovery, a beneficial effect in part phenocopied by supplementation of lipophilic antioxidants vitamin E and Lands cycle fueling via L-carnitine, and in part ablated by GPX4 inhibition via the covalent inhibitor ML210. This study offers mechanistic insights into RBC ferroptosis and positions GPX4 genetic status as a promising biomarker for precision transfusion medicine.

29 March 2017 in Cancer Causes & Control
Verified
Journal Article
Closed access
PDF file
AMAmy Moore
Amy Moore
QLQing Lan
Qing Lan
JHJonathan Hofmann
Jonathan Hofmann
CLChin-San Liu
Chin-San Liu
WCWen-Ling Cheng
Wen-Ling Cheng
SBSonja I. Berndt
Sonja I. Berndt

24 November 2023 in Communications Biology
Verified
Journal Article
Open access
PDF file
AMAmy Moore
Amy Moore
JMJesse A. Marks
Jesse A. Marks
BQBryan C. Quach
Bryan C. Quach
YGYuelong Guo
Yuelong Guo
LBLaura J. Bierut
Laura J. Bierut
EJEric O. Johnson
Eric O. Johnson
Where sufficiently large genome-wide association study (GWAS) samples are not currently available or feasible, methods that leverage increasing knowledge of the biological function of variants may illuminate discoveries without increasing sample size. We comprehensively evaluated 17 functional weighting methods for identifying novel associations. We assessed the performance of these methods using published results from multiple GWAS waves across each of five complex traits. Although no method achieved both high sensitivity and positive predictive value (PPV) for any trait, a subset of methods utilizing pleiotropy and expression quantitative trait loci nominated variants with high PPV (>75%) for multiple traits. Application of functionally weighting methods to enhance GWAS power for locus discovery is unlikely to circumvent the need for larger sample sizes in truly underpowered GWAS, but these results suggest that applying functional weighting to GWAS can accurately nominate additional novel loci from available samples for follow-up studies.

11 September 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
TNTravis Nemkov
Travis Nemkov
DSDaniel Stephenson
Daniel Stephenson
EEEric J. Earley
Eric J. Earley
GKGregory R Keele
Gregory R Keele
AHAriel Hay
Ariel Hay
Angelo D'AlessandroAngelo D'Alessandro
Angelo D'Alessandro
Glycolysis is a central metabolic pathway in health and disease,1 an essential one in mature red blood cells (RBCs), which rely on the Embden-Meyerhof-Parnas pathway, i.e., glycolysis, as the sole source of energy generation.2 During aging in vivo and in vitro under blood bank conditions,3 the adenosine triphosphate (ATP) generated via glycolysis in mitochondria-devoid mature RBCs is essential for the modulation of oxygen kinetics,4 deformability2 and, ultimately, intra- and extra-vascular hemolysis.3 Here we draw upon a cohort of 13,029 volunteers from the Recipient Epidemiology and Donor Evaluation Study (REDS) to identify biological and genetic traits associated with heterogeneity in glycolytic phenotypes. Age, sex and ethnicity influenced glycolysis, with additional effects due to genetic polymorphisms in regions coding for rate-limiting enzymes of glycolysis,1 phosphofructokinase 1 (PFKP) and hexokinase 1 (HK1), and for the ADP-ribosyl cyclase CD38. The gene-metabolite associations were validated by testing glycolysis in fresh and stored RBCs from 350 Diversity Outbred mice.5 These findings were further corroborated via multi-omics analyses of 1,929 samples at storage day 10, 23 and 42 in 643 RBC units from donors who were selected amongst the index cohort based on their extreme hemolytic propensity. Finally, we show that glycolysis, ATP levels, breakdown and deamination into hypoxanthine are associated with increased hemolytic propensity and vesiculation ex vivo, as well as with extravascular hemolysis in vivo, both in healthy autologous transfusion recipients from the Donor Iron Deficiency Study and in 4,700 heterologous critically ill patients receiving blood products from the REDS donors. This work advances our understanding of genetic and non-genetic factors that regulate glycolysis in mature RBCs, a simplified model of mammalian cell metabolism,6 a cell type where dysregulated glycolysis holds broader implications in hemolytic disorders, offering potential avenues for novel therapeutic interventions and transfusion strategies.

28 March 2018 in Cancer Causes & Control
Verified
Journal Article
Closed access
PDF file
AMAmy Moore
Amy Moore
WHWen-Yi Huang
Wen-Yi Huang
KDKim Danforth
Kim Danforth
RFRoni Falk
Roni Falk
AMAllison Meade
Allison Meade
SBSonja I. Berndt
Sonja I. Berndt